News
Immunotherapeutic treatments for celiac disease focus of vis...
Dr Bob Anderson, Chief Scientific Officer at immunotherapeutic company ImmusanT, rece...
Latest funding recognising impact of Malaghan scientists
Malaghan Institute of Medical Research scientists have been recognised for their high...
The final leg of the Great New Zealand Trek
Fourteen years, 2,613 kilometres and over $450,000 raised towards multiple sclerosis ...
Allergy research honours in Burnet Oration
The oration is named after the Nobel prize-winning Australian immunologist Sir Fr...
Building a better future
From pipettes to high-powered microscopes, from petri dishes to million-dollar cell s...
Immunotherapy profoundly changing the way we treat cancer
Director of the Malaghan Institute of Medical Research Professor Graham Le Gros says...
Visiting speaker: Dr. David Sacks, NIH Washington D.C.
Dr. David Sacks from the National Institutes of Health, Washington D.C., visited the ...
Celebrating a quarter of a century at the Malaghan Institute
This April marks 25 years since Institute Director Professor Graham Le Gros an...
Technology team building on world-class cytometry platform
State-of-the-art technology has been vital to our ground-breaking research and discov...
Malaghan Institute annual appeal 2019
Thank you for supporting our work to fundamentally change how we prevent, treat and c...